Experimental autoimmune encephalomyelitis--achievements and prospective advances.
about
Oligodendrogenesis in the normal and pathological central nervous systemLive imaging of targeted cell ablation in Xenopus: a new model to study demyelination and repair.Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitorsThe extracellular domain of myelin oligodendrocyte glycoprotein elicits atypical experimental autoimmune encephalomyelitis in rat and Macaque speciesICAM-1: isoforms and phenotypes.Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.Passive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells.High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activationNovel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.Mechanisms regulating regional localization of inflammation during CNS autoimmunity.Mature dendritic cells cause Th17/Treg imbalance by secreting TGF-β1 and IL-6 in the pathogenesis of experimental autoimmune encephalomyelitis.The therapeutic potential of interleukin-10 in neuroimmune diseases.Tolerogenic vaccines for Multiple sclerosisPERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseasesUsing EAE to better understand principles of immune function and autoimmune pathologyOpportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.Immune modulation by curcumin: The role of interleukin-10.New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis.Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody.MR imaging of the yucatan pig head and neck vasculature.Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
P2860
Q21129352-9CD73EDD-AC5D-4FD9-A5A0-2961E45B050BQ30525337-66E6B62C-84DA-46ED-A9FD-265960FD7236Q33651898-02F58DBF-2464-4B6B-88D3-A7487EFE4E0CQ34295282-B04ED8F2-0664-4965-BA3B-731273626A4DQ34323535-C14212BB-271F-451E-BAC9-EDF7DDD9961BQ34418742-1E39A2BD-E411-4473-BFDF-2D3D7968A0D4Q34451923-3B5672C3-1997-4F90-9CD0-309E2AED4766Q34540602-0D46587F-8C57-40F6-BF51-97B4C2004941Q35223938-5C948847-2D63-44F7-B0B2-BE31DAEC75BAQ36088247-69081274-64BF-42B6-8A92-84DF37F2D244Q36485290-F3E8A993-1A0A-4ED2-B7E7-7E63AA1B6D4CQ36604934-C901B387-F8A4-4A29-9DB2-7A3D155E787BQ36908003-6A7BFEE8-F7CF-42DB-8EEE-F1A8CEDC8A75Q36918129-E1E85DCF-02DD-4744-8D92-D4A299B27F6FQ37140600-C5630832-F9DB-4A82-AE30-7BD1DDBE7460Q37485007-F5CFF326-1A86-41B6-BBA5-A88AB18D0ADAQ37505364-8123BDD3-40CF-4B7C-A5B5-BFE9CD485F52Q37530805-B66BB0D5-52D5-4819-A282-E6D26ACAD350Q37657501-881B1B57-6217-4B53-8FF4-D9FCA8B3B996Q37670027-8C2C7537-84E3-4723-8166-10B6867FC73CQ38103283-E6AB53C1-EDCF-4687-9B2C-7677CAAE8328Q40097338-C56C7F63-F1C8-4BF8-8AB3-18672357D9ABQ41459008-5448AD14-BE1A-40E5-9B97-3ED83B0F4BD2Q41523208-494FD988-B754-4266-B3A6-C92767038F1CQ43568396-53923DE0-0526-4BDB-9FBA-944AB511FEA1Q46816215-F29524DC-4E49-4635-BCE9-3A0B492F5E4BQ48089426-5DEF13DE-699D-453B-BEB9-6B48591BDA5FQ51064476-84B674FC-283B-4230-AF13-BBF11977DD2D
P2860
Experimental autoimmune encephalomyelitis--achievements and prospective advances.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Experimental autoimmune encephalomyelitis--achievements and prospective advances.
@en
Experimental autoimmune encephalomyelitis--achievements and prospective advances.
@nl
type
label
Experimental autoimmune encephalomyelitis--achievements and prospective advances.
@en
Experimental autoimmune encephalomyelitis--achievements and prospective advances.
@nl
prefLabel
Experimental autoimmune encephalomyelitis--achievements and prospective advances.
@en
Experimental autoimmune encephalomyelitis--achievements and prospective advances.
@nl
P2093
P2860
P1476
Experimental autoimmune encephalomyelitis--achievements and prospective advances.
@en
P2093
Helena Batoulis
Klaus Addicks
Mascha S Recks
Stefanie Kuerten
P2860
P304
P356
10.1111/J.1600-0463.2011.02794.X
P577
2011-10-18T00:00:00Z